Biopharm Analytica Biotechnology and Pharmaceutical Business News Service

HOME
MY ACCOUNT
CONTACT US
ABOUT US
NEWS
NEWS ARCHIVE
REPORTS
EVENTS
COMPANIES
WHOS WHO
IMAGE LIBRARY
CONSULTING SERVICES
LINKS
SEARCH
   
   
  GO
   

    BIOPHARM ANALYTICA
About Us

Founded in February 2005, Biopharm Analytica Limited is a spin out company which has its origins in a major research project focusing on the Russian Biopharmaceutical Industry, formerly based at the Centre for Russian & East European Studies (CREES), European Research Institute, The University of Birmingham. Among the major outputs from this research are: a PhD on Biotechnology in the USSR; one Master's dissertation on Some Aspects of Single Cell Protein Production in the USSR; and the first Western academic book on Russia's emerging biotechnology industry, Technology and Transition: A Survey of Biotechnology in Russia, Ukraine and the Baltic States. As an integral component of the project, three major reports on the biopharmaceutical industry in Kazakhstan, Belarus and Uzbekistan were completed for the United Kingdom's Department of Trade & Industry. A number of papers have also been published on aspects of biotechnology regulations in Russia and the NIS, including a report on Biotechnology Legislation in Central & Eastern Europe for the European Federation of Biotechnology. Numerous missions were undertaken with the aim of facilitating links between UK companies and lead-edge researchers and the most significant biotech and pharmaceutical companies in the Russian Federation and NIS. A number of key reference books on Russian and NIS biotechnology have also been published including Who's Who in Russia & Republics Biotechnology and Ex-USSR Biotechnology Industry Contact Directory. Numerous seminars and conference reports have been delivered including presentations to the NATO Economics Colloquium and the NATO Symposium on Science in Eastern Europe. Researchers at the project also acted as consultants for a number of national and international pharmaceutical companies with an interest in exploring opportunities in Russia and the NIS.

Biopharm Analytica utilises the academic resources developed over more than a decade at the Birmingham project to provide new insight into the biopharmaceutical industries of Russia and the Newly Independent States. Utilising a wide network of academic and business contacts the company undertakes research and consultancy for international companies seeking to access the Russian pharma and biotech market.

Biopharm Analytica Limited's Registered Office is located at Suite B, 29 Harley Street, London, W1G 9QR. Registered in England and Wales. Reg. No. 5360763. VAT Reg. No. 930 3219 57.


Login to your account

What's New?
23/7/2010
Belarus Pharmaceuticals and Healthcare Report Q3 2010

14/7/2010
Conference on Regional Biosafety & Biosecurity Collaboration (Bishkek)

8/7/2010
Conference on Logistics of the Russian Pharma Market (Moscow)


Latest News
23/7/2010
Candidate HIV Vaccine Developed in Novosibirsk Wins Approval for Clinical Trials

New Report Estimates Belarus Pharma Market to Grow to U.S.$1.05 Billion by 2014

22/7/2010
U.S.$250-300 Million Irkutsk Biobutanol Project Set for Relaunch in September 2010

21/7/2010
Biokad & Geropharm to Invest U.S.$69 Million in Establishing St. Petersburg Pharma Production

20/7/2010
Thermo Fisher Scientific Completes U.S.$260 Million Acquisition of Lithuania's Fermentas

Biotechnology and Pharmaceutical Business News Service focusing on Russia and the Newly Independent States.
© 2003 - 2007 Biopharm Analytica. All rights reserved.